The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Fri., Dec. 6, 8:13 PM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #73. Intrexon Corporation Laboratory Operations from Codexis

Acquirer: Intrexon Corporation (NASDAQ:XON)
Acquiree: Laboratory Operations from Codexis
Details: Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that it has acquired state-of-the-art laboratory operations in Budapest, Hungary from Codexis, Inc., a developer of biocatalysts for the pharmaceutical and complex chemistry industries.

Intrexon is engaged in the field of synthetic biology, focusing on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. Using its suite of technologies, Co. designs, builds and regulates gene programs, which are DNA sequences that consist of primary genetic components. A single gene program or a complex, multi-genic program is fabricated and stored within a DNA vector. Vectors are segments of DNA used as a vehicle to transmit genetic information. Co.'s primary domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Hungary.

XON SEC Filing Email Alerts Service


Open the XON Page at The Online Investor »

Company Name: 
Intrexon Corp
Website: 
www.dna.com
Sector: 
Biotechnology
Number of ETFs Holding XON: 
25
Total Market Value Held by ETFs: 
$54.50M
Total Market Capitalization: 
$878.00M
% of Market Cap. Held by ETFs: 
6.21%
 

Open the XON Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Hold (1.67 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 73 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.